Market Overview

Alnylam Pharmaceuticals Prices 8M Share Offering at $20.13/Share

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) announced Tuesday, the pricing of an underwritten
registered public offering of 8,000,000 shares of its common stock at a
public offering price of $20.13 per share. All of the shares in the
offering are to be sold by Alnylam. The offering is expected to close on
or about January 22, 2013, subject to the satisfaction of customary
closing conditions.

J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC are acting as
joint book-running managers and representatives of the underwriters for
the offering. Deutsche Bank Securities Inc., Piper Jaffray & Co.,
Leerink Swann LLC, Needham & Company, LLC and JMP Securities LLC are
acting as

See full press release

Posted-In: News Guidance Contracts Management Global

 

Related Articles (ALNY)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters